Back to Feed
总结
英国媒体报道，英格兰国家医疗服务体系（NHS）将扩大一款延长寿命的前列腺癌药物在英格兰的可及性，预计让成千上万名男性患者更早或更广泛地获得治疗。报道指该药物成本较低（有报道称每片约2.50英镑），通过调整适用范围与用药路径，NHS希望在不显著增加预算压力的情况下提升生存获益，并减少晚期治疗与住院带来的负担。该举措被称可能“挽救数千条生命”，具体实施与受益人群将随NHS政策落地推进。
正文
NHS expands access to prostate cancer drug in England to save thousands of lives The Guardian Life-extending prostate cancer drug to be offered to thousands in England BBC Thousands more men to be offered life-extending prostate cancer drug on NHS ITVX Drug costing just £2.50 will extend life of prostate cancer patients The Times Thousands of men to receive prostate cancer drug on NHS The Telegraph
发布时间：